Time to Remission for Depression with Collaborative Care Management (CCM) in Primary Care

Journal of the American Board of Family Medicine : JABFM
Gregory M GarrisonTimothy W Lineberry

Abstract

Collaborative care management (CCM) has been shown to have superior outcomes to usual care (UC) for depressed patients with a fixed end point. This study was a survival analysis over time comparing CCM with UC using remission (9-item Patient Health Questionnaire [PHQ-9] score <5) and persistent depressive symptoms (PDSs; PHQ-9 score ≥10) as end points. A retrospective cohort study of 7340 patients with depression cared for at 4 outpatient primary care clinics was conducted from March 2008 through June 2013. All adult patients diagnosed with depression (International Classification of Diseases, 9th Revision [ICD-9], codes 296.2-3) or dysthymia (ICD-9 code 300.4) with an initial PHQ-9 score ≥10 were included. CCM was implemented at all clinics between 2008 and 2010. Kaplan-Meyer survival curves for time to remission and PDSs were plotted. A Cox proportional hazards model was used to adjust for expected differences between patients choosing CCM versus UC. Median time to remission was 86 days (95% confidence interval [CI], 81-91 days) for the CCM group versus 614 days (95% CI, 565-692 days) for the UC group. Likewise, median duration of PDSs was 31 days (95% CI, 30-33 days) for the CCM group versus 154 days (95% CI, 138-182 days) f...Continue Reading

Citations

Sep 30, 2017·Journal of Occupational and Environmental Medicine·Akuh AdajiMark Williams
Sep 12, 2017·Health Services Research and Managerial Epidemiology·Daniel R WittKurt B Angstman
Feb 10, 2018·Journal of General Internal Medicine·Beth WaitzfelderGregory E Simon
Oct 12, 2018·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Mai-Khanh Bui-DuyLeah S Karliner
Jun 24, 2020·Environmental Management·Amanda K Martin, Karen V Root
May 17, 2019·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Mai-Khanh Bui-DuyLeah S Karliner
Jan 23, 2020·Translational Behavioral Medicine·Mark D Williams
Jul 16, 2019·Journal of Primary Care & Community Health·Joseph A AkambaseKurt B Angstman
Jul 16, 2020·Current Psychiatry Reports·Olivia E BoguckiCraig N Sawchuk
Jun 25, 2021·Journal of Affective Disorders·Kurt B AngstmanGregory M Garrison
Aug 7, 2021·Journal of Primary Care & Community Health·John Blade HargissGregory M Garrison
Sep 19, 2021·Journal of the American Geriatrics Society·Brenna N RennJürgen Unützer
Aug 28, 2020·Cerebrovascular Diseases Extra·Laura K SteinMandip S Dhamoon
Nov 18, 2021·Multiple Sclerosis : Clinical and Laboratory Research·Emily M SchorrMandip S Dhamoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.